Smith Nephew Oxinium Knee Replacement

Consumer Alert: Smith & Nephew Issues a Recall on Oxinium Cementless Knee Replacements

Smith & Nephew, the international medical device conglomerate, headquartered in London, England, researches, develops, and markets medical orthopedic, endoscopic, and wound management products to medical communities throughout the world. Smith & Nephew developed cementless knee replacement implants, known as Oxinium Genesis II and Oxinium Profix II.

These Oxinium knee components worked more efficiently than the original metal cobalt chrome or titanium knee replacements of the past. The Oxinium implants reduce the amount of rubbing and resistance between the replacement components and surrounding tissue areas [i].

In the past, cobalt chrome or titanium based metals were considered the best material for knee replacements because of wear resistance. However, recent studies indicate that cobalt chrome femoral implants wear over time [ii]. When cobalt chrome or titanium is exposed to large amounts of stress from daily activity such as walking, it produces particles of matter, which produce inflammation known as osteolysis [iii].

The Oxinium knee replacement became a commonly used surgical procedure because of the increasing prevalence of knee replacement surgery; approximately 300,000 knee replacement procedures are performed in the United States annually. Approximately 3,000 patients had the Oxinium knee replacement [iv].

In August 2003, Smith & Nephew sent an alert to the US Food and Drug Administration after an Oxinium product defect was discovered [v]. Then, in September 2003, Smith & Nephew issued a recall on the design and function of the cementless knee implant in the United States. The macrotexturing surface failed to provide proper bonding to the bone, leading to increased pain and loosened knee joints. As of February 2005, approximately 26% (782 out of 2971 cases) of the Oxinium knee implants required revision surgery [v].

A number of these cementless knee implants are defective, causing increased amounts of pain, increased risks of revision surgery, infections, swelling and inflammation, more joint, tissue, and/or muscular damage, and increased rehabilitation.

Have you or a loved one had an Oxinium cementless knee replacement? Contact us.


  1. Smith & Nephew Product Portfolio. (2005). Orthopedics Oxinium Genesis II and Profix II Knee Systems. London, England
  2. Burns, Andrew. (2003). Smith & Nephew Advances Unicondylar Knee Surgery with Accuris Instrument and Oxinium Implant. London, England
  3. Cemented and Cementless Knee Replacements (2001). American Academy of Orthopedic Surgeons. Rosemont, IL
  4. Knee Replacement: Surgery Can Relieve Pain (October 2005); Mayo Clinic Health Information Division. Rochester, MN.
  5. Smith & Nephew: Risk Reports (2004 Annual Report). London, England
Contact Now
Image text Send e-mail
Apr 16 2014
This successful yearly program will present speakers from civil, criminal and workers compensation backgrounds who will offer rapid-fire hot tips of relevance to all litigators.
Apr 16 2014
Don't miss this first public presentation and discussion of a program that will have a significant impact on the way in which Track I and Track II cases are handled Friday May 16, 2014 12pm-1:30pm at the Borgata
Apr 04 2014

On April 12, 2014 Honorable C. Judson Hamlin to be honored at the Douglass Founders Day Awards Recognition Luncheon: Douglass Medal: Honorable C. Judson Hamlin

Mar 26 2014
The Law offices of Keefe Bartels announce that five of their attorneys have been selected as 2014 New Jersey Super Lawyers. The attorneys designated as 2014 New Jersey Super Lawyers, and the practice area for which they were chosen, are:
Feb 26 2014
Keefe Bartels is investigating alleged claims of serious and sometimes fatal side effects suffered by patients who were prescribed “Low T” drugs for testosterone therapy, or TT.  
Feb 17 2014
John E. Keefe, Jr. and Patrick J. Bartels announce Danyelle Shapiro as new associate to Keefe Bartels.
Jan 10 2014
On January 7, 2014, Governor Chris Christie held a ceremonial signing of the New Jersey Dream Act at Colin Powell School in Union City, New Jersey.  This legislation grants in-state tuition benefits to undocumented students living in New Jersey.
Dec 01 2013
John E. Keefe, Jr. and Patrick J. Bartels announce John E. Gregory, Jr. as new partner to Keefe Bartels.  John joined the firm in September of 2005 as an associate attorney.  Since that time John has litigated hundreds of cases on behalf of the firm's clients, taking many of those cases to trial throughout New Jersey. 
Nov 21 2013
Livingston, Dimarzio and Baptista, LLP Secures Settlement in New Jersey Prison Workers' Compensation Case Bucci vs. Rahway State Prison Results in $595,890 Award for Prison Guard Widow. Click here to read the full press release.
Nov 20 2013
Joshua Kincannon of Keefe Bartels is featured in "J&J will pay $2.5B to settle hip implant lawsuits" article of the Asbury Park Press. Click here to read the full post.
Subscribe to our eNews
For Email Marketing you can trust